Table 2.
Most differentially expressed proteins using a 1.5-fold change (EAAs vs whey group), log2 fold change > 0.585 (upregulated), < − 0.585 (downregulated), and − log10 p > 1.3 (significant)
Differentially Expressed Proteins in EAAs vs whey group | Log2 fold change (EAA vs whey) | − Log10 of p-value | Fold change (EAA vs whey) | Effect size | |
---|---|---|---|---|---|
A: upregulated proteins (EAAs vs whey group) | |||||
1. | Adenylate kinase isoenzyme 1 | 1.05 | 1.49 | 2.071 | 2.08 |
2. | Casein kinase II 2-alpha:2-beta heterotetramer | 0.729 | 1.41 | 1.657 | 2.23 |
3. | Nascent polypeptide-associated complex subunit alpha | 0.740 | 1.34 | 1.670 | 2.30 |
4. | Peroxiredoxin-1 | 0.607 | 2.24 | 1.524 | 2.17 |
5. | Peroxiredoxin-6 | 0.721 | 1.35 | 1.648 | 2.75 |
B: downregulated proteins (EAAs vs whey group) | |||||
6. | Glycerol-3-phosphate dehydrogenase [NAD( +)], cytoplasmic | − 0.888 | 1.52 | 0.540 | 1.37 |
7. | Endoglin | − 0.608 | 1.33 | 0.656 | 1.23 |
8. | C–C motif chemokine 3 | − 0.718 | 1.45 | 0.608 | 1.10 |
9. | Mast/stem cell growth factor receptor Kit | − 0.654 | 2.89 | 0.636 | 2.81 |
10. | Interleukin-18-binding protein | − 0.753 | 2.34 | 0.593 | 1.68 |
11. | Regenerating islet-derived protein 4 | − 0.687 | 1.64 | 0.621 | 1.22 |
12. | Peptide YY | − 0.607 | 1.48 | 0.657 | 1.25 |
13. | Glucagon | − 1.16 | 1.59 | 0.447 | 1.19 |
14. | NADPH–cytochrome P450 reductase | − 1.05 | 1.76 | 0.483 | 1.32 |
15. | Formimidoyltransferase-cyclodeaminase | − 1.68 | 1.70 | 0.312 | 1.26 |
16. | Aminoacylase-1 | − 0.808 | 2.00 | 0.571 | 1.54 |
17. | Ectonucleoside triphosphate diphosphohydrolase 5 | − 0.606 | 3.07 | 0.657 | 2.48 |
18. | Creatine kinase M-type:Creatine kinase B-type heterodimer | − 0.847 | 1.37 | 0.556 | 1.24 |
19. | N-acylethanolamine-hydrolyzing acid amidase | − 0.677 | 1.65 | 0.625 | 1.27 |
20. | Low affinity immunoglobulin gamma Fc region receptor II-b | − 0.667 | 1.80 | 0.630 | 2.07 |